1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Radiopharmaceuticals Market, by Type
6.1. Introduction
6.2. Diagnostic Nuclear Medicine
6.2.1. Pet Radiopharmaceuticals
6.2.1.1. F-18
6.2.1.2. Ru-82
6.2.2. Spect Radiopharmaceuticals
6.2.2.1. Ga-67
6.2.2.2. I-123
6.2.2.3. Tc-99m
6.2.2.4. Tl-201
6.3. Therapeutic Nuclear Medicine
6.3.1. Alpha Emitters
6.3.2. Beta Emitters
6.3.2.1. I-131
6.3.2.2. Lu-177
6.3.2.3. Re-186
6.3.2.4. Sm-153
6.3.2.5. Y-90
6.3.3. Brachytherapy Isotopes
6.3.3.1. Cs-131
6.3.3.2. I-125
6.3.3.3. Ir-192
6.3.3.4. Pd-103

7. Radiopharmaceuticals Market, by Procedural Volume
7.1. Introduction
7.2. Diagnostic Procedures
7.2.1. Pet Radiopharmaceutical Procedure
7.2.2. Spect Radiopharmaceuticals Procedure
7.3. Therapeutic Procedures
7.3.1. Alpha Emitter Procedure
7.3.2. Beta Emitters Procedure
7.3.3. Brachytherapy Isotopes Procedure

8. Radiopharmaceuticals Market, by Application
8.1. Introduction
8.2. Diagnostic Applications
8.2.1. Pet Applications
8.2.1.1. Cardiology Indication
8.2.1.2. Neurology Indication
8.2.1.3. Oncology Indication
8.2.2. Spect Applications
8.2.2.1. Cardiology
8.2.2.2. Lymphoma
8.2.2.3. Neurology
8.2.2.4. Thyroid
8.3. Therapeutic Applications
8.3.1. Bone Metastasis
8.3.2. Endocrine Tumors
8.3.3. Lymphoma Therapeutic
8.3.4. Thyroid Therapeutic

9. California Radiopharmaceuticals Market

10. Florida Radiopharmaceuticals Market

11. Illinois Radiopharmaceuticals Market

12. New York Radiopharmaceuticals Market

13. Ohio Radiopharmaceuticals Market

14. Pennsylvania Radiopharmaceuticals Market

15. Texas Radiopharmaceuticals Market

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion

17. Company Usability Profiles
17.1. Advanced Accelerator Applications S.A
17.2. Alliance Medical
17.3. Bayer AG
17.4. Bracco Imaging SpA
17.5. Cardinal Health, Inc.
17.6. Clarity Pharmaceuticals
17.7. Curium France SASU
17.8. Eckert & Ziegler
17.9. Eczacibasi-Monrol Nuclear Products Co.
17.10. Fusion Pharma
17.11. GE Healthcare Inc
17.12. Global Medical Solutions, LTD.
17.13. Institute of Isotopes Co., LTD.
17.14. IsoTherapeutics Group, LLC
17.15. Isotopia Molecular Imaging Limited
17.16. Joint Stock Company Isotope
17.17. Jubilant Pharma Holdings Inc.
17.18. Lantheus Medical Imaging, Inc.
17.19. Mallinckrodt PLC
17.20. Medtronic PLC
17.21. Navidea Biopharmaceuticals, Inc.
17.22. Nordion, Inc.
17.23. Northstar Medical Radioisotopes, LLC
17.24. NTP Radioisotopes Soc, LTD.
17.25. Pharmalogic
17.26. Shine Medical Technologies
17.27. Siemens Healthineers AG
17.28. Sigma- Aldrich Corporation
17.29. Sinotau Pharmaceuticals Group

18. Appendix
18.1. Discussion Guide
18.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES RADIOPHARMACEUTICALS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES RADIOPHARMACEUTICALS MARKET: MARKET DYNAMICS
FIGURE 3. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2020 VS 2027 (%)
FIGURE 4. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2027
FIGURE 6. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2018-2027 (USD MILLION)
FIGURE 7. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 8. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2018-2027 (USD MILLION)
FIGURE 9. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY F-18, 2018-2027 (USD MILLION)
FIGURE 11. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY F-18, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 12. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY RU-82, 2018-2027 (USD MILLION)
FIGURE 13. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY RU-82, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 14. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2018-2027 (USD MILLION)
FIGURE 15. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 16. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY GA-67, 2018-2027 (USD MILLION)
FIGURE 17. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY GA-67, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 18. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY I-123, 2018-2027 (USD MILLION)
FIGURE 19. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY I-123, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 20. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY TC-99M, 2018-2027 (USD MILLION)
FIGURE 21. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY TC-99M, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 22. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY TL-201, 2018-2027 (USD MILLION)
FIGURE 23. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY TL-201, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 24. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2018-2027 (USD MILLION)
FIGURE 25. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 26. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, 2018-2027 (USD MILLION)
FIGURE 27. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 28. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2018-2027 (USD MILLION)
FIGURE 29. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 30. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY I-131, 2018-2027 (USD MILLION)
FIGURE 31. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY I-131, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 32. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY LU-177, 2018-2027 (USD MILLION)
FIGURE 33. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY LU-177, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 34. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY RE-186, 2018-2027 (USD MILLION)
FIGURE 35. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY RE-186, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 36. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SM-153, 2018-2027 (USD MILLION)
FIGURE 37. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SM-153, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 38. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY Y-90, 2018-2027 (USD MILLION)
FIGURE 39. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY Y-90, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 40. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2018-2027 (USD MILLION)
FIGURE 41. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 42. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY CS-131, 2018-2027 (USD MILLION)
FIGURE 43. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY CS-131, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 44. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY I-125, 2018-2027 (USD MILLION)
FIGURE 45. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY I-125, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 46. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY IR-192, 2018-2027 (USD MILLION)
FIGURE 47. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY IR-192, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 48. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PD-103, 2018-2027 (USD MILLION)
FIGURE 49. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PD-103, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 50. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2020 VS 2027 (%)
FIGURE 51. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2020 VS 2027 (USD MILLION)
FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2027
FIGURE 53. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2018-2027 (USD MILLION)
FIGURE 54. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 55. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICAL PROCEDURE, 2018-2027 (USD MILLION)
FIGURE 56. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICAL PROCEDURE, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 57. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS PROCEDURE, 2018-2027 (USD MILLION)
FIGURE 58. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS PROCEDURE, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 59. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2027 (USD MILLION)
FIGURE 60. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 61. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTER PROCEDURE, 2018-2027 (USD MILLION)
FIGURE 62. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTER PROCEDURE, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 63. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS PROCEDURE, 2018-2027 (USD MILLION)
FIGURE 64. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS PROCEDURE, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 65. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES PROCEDURE, 2018-2027 (USD MILLION)
FIGURE 66. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES PROCEDURE, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 67. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2020 VS 2027 (%)
FIGURE 68. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2020 VS 2027 (USD MILLION)
FIGURE 69. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2027
FIGURE 70. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2027 (USD MILLION)
FIGURE 71. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 72. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2018-2027 (USD MILLION)
FIGURE 73. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 74. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY INDICATION, 2018-2027 (USD MILLION)
FIGURE 75. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY INDICATION, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 76. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY INDICATION, 2018-2027 (USD MILLION)
FIGURE 77. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY INDICATION, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 78. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY INDICATION, 2018-2027 (USD MILLION)
FIGURE 79. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY INDICATION, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 80. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2018-2027 (USD MILLION)
FIGURE 81. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 82. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2018-2027 (USD MILLION)
FIGURE 83. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 84. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, 2018-2027 (USD MILLION)
FIGURE 85. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 86. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2018-2027 (USD MILLION)
FIGURE 87. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 88. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, 2018-2027 (USD MILLION)
FIGURE 89. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 90. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2018-2027 (USD MILLION)
FIGURE 91. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 92. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BONE METASTASIS, 2018-2027 (USD MILLION)
FIGURE 93. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BONE METASTASIS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 94. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY ENDOCRINE TUMORS, 2018-2027 (USD MILLION)
FIGURE 95. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY ENDOCRINE TUMORS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 96. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA THERAPEUTIC, 2018-2027 (USD MILLION)
FIGURE 97. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA THERAPEUTIC, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 98. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID THERAPEUTIC, 2018-2027 (USD MILLION)
FIGURE 99. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID THERAPEUTIC, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 100. UNITED STATES RADIOPHARMACEUTICALS MARKET: FPNV POSITIONING MATRIX
FIGURE 101. UNITED STATES RADIOPHARMACEUTICALS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 102. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES RADIOPHARMACEUTICALS MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES RADIOPHARMACEUTICALS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, BY STATE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY F-18, BY STATE, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY RU-82, BY STATE, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, BY STATE, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY GA-67, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY I-123, BY STATE, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY TC-99M, BY STATE, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY TL-201, BY STATE, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, BY STATE, 2018-2027 (USD MILLION)
TABLE 14. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 15. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY I-131, BY STATE, 2018-2027 (USD MILLION)
TABLE 17. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY LU-177, BY STATE, 2018-2027 (USD MILLION)
TABLE 18. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY RE-186, BY STATE, 2018-2027 (USD MILLION)
TABLE 19. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SM-153, BY STATE, 2018-2027 (USD MILLION)
TABLE 20. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY Y-90, BY STATE, 2018-2027 (USD MILLION)
TABLE 21. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, BY STATE, 2018-2027 (USD MILLION)
TABLE 22. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY CS-131, BY STATE, 2018-2027 (USD MILLION)
TABLE 23. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY I-125, BY STATE, 2018-2027 (USD MILLION)
TABLE 24. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY IR-192, BY STATE, 2018-2027 (USD MILLION)
TABLE 25. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PD-103, BY STATE, 2018-2027 (USD MILLION)
TABLE 26. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2027 (USD MILLION)
TABLE 27. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY STATE, 2018-2027 (USD MILLION)
TABLE 28. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICAL PROCEDURE, BY STATE, 2018-2027 (USD MILLION)
TABLE 29. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS PROCEDURE, BY STATE, 2018-2027 (USD MILLION)
TABLE 30. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, BY STATE, 2018-2027 (USD MILLION)
TABLE 31. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTER PROCEDURE, BY STATE, 2018-2027 (USD MILLION)
TABLE 32. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS PROCEDURE, BY STATE, 2018-2027 (USD MILLION)
TABLE 33. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES PROCEDURE, BY STATE, 2018-2027 (USD MILLION)
TABLE 34. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 35. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY STATE, 2018-2027 (USD MILLION)
TABLE 36. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, BY STATE, 2018-2027 (USD MILLION)
TABLE 37. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY INDICATION, BY STATE, 2018-2027 (USD MILLION)
TABLE 38. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY INDICATION, BY STATE, 2018-2027 (USD MILLION)
TABLE 39. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY INDICATION, BY STATE, 2018-2027 (USD MILLION)
TABLE 40. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, BY STATE, 2018-2027 (USD MILLION)
TABLE 41. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY STATE, 2018-2027 (USD MILLION)
TABLE 42. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, BY STATE, 2018-2027 (USD MILLION)
TABLE 43. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY STATE, 2018-2027 (USD MILLION)
TABLE 44. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, BY STATE, 2018-2027 (USD MILLION)
TABLE 45. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY STATE, 2018-2027 (USD MILLION)
TABLE 46. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BONE METASTASIS, BY STATE, 2018-2027 (USD MILLION)
TABLE 47. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY ENDOCRINE TUMORS, BY STATE, 2018-2027 (USD MILLION)
TABLE 48. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA THERAPEUTIC, BY STATE, 2018-2027 (USD MILLION)
TABLE 49. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID THERAPEUTIC, BY STATE, 2018-2027 (USD MILLION)
TABLE 50. UNITED STATES RADIOPHARMACEUTICALS MARKET: SCORES
TABLE 51. UNITED STATES RADIOPHARMACEUTICALS MARKET: BUSINESS STRATEGY
TABLE 52. UNITED STATES RADIOPHARMACEUTICALS MARKET: PRODUCT SATISFACTION
TABLE 53. UNITED STATES RADIOPHARMACEUTICALS MARKET: RANKING
TABLE 54. UNITED STATES RADIOPHARMACEUTICALS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 55. UNITED STATES RADIOPHARMACEUTICALS MARKET: MERGER & ACQUISITION
TABLE 56. UNITED STATES RADIOPHARMACEUTICALS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 57. UNITED STATES RADIOPHARMACEUTICALS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 58. UNITED STATES RADIOPHARMACEUTICALS MARKET: INVESTMENT & FUNDING
TABLE 59. UNITED STATES RADIOPHARMACEUTICALS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 60. UNITED STATES RADIOPHARMACEUTICALS MARKET: LICENSE & PRICING

Companies Mentioned

Advanced Accelerator Applications S.A
Alliance Medical
Bayer AG
Bracco Imaging SpA
Cardinal Health, Inc.
Clarity Pharmaceuticals
Curium France SASU
Eckert & Ziegler
Eczacibasi-Monrol Nuclear Products Co.
Fusion Pharma
GE Healthcare Inc
Global Medical Solutions, LTD.
Institute of Isotopes Co., LTD.
IsoTherapeutics Group, LLC
Isotopia Molecular Imaging Limited
Joint Stock Company Isotope
Jubilant Pharma Holdings Inc.
Lantheus Medical Imaging, Inc.
Mallinckrodt PLC
Medtronic PLC
Navidea Biopharmaceuticals, Inc.
Nordion, Inc.
Northstar Medical Radioisotopes, LLC
NTP Radioisotopes Soc, LTD.
Pharmalogic
Shine Medical Technologies
Siemens Healthineers AG
Sigma- Aldrich Corporation
Sinotau Pharmaceuticals Group